(Q47308315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Luis San

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

B Arranz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

R M Dueñas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

M Centeno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

N Ramirez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

J Salavert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

E Del Moral

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

published in

Human Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

11-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

23 December 2019

cites work

1 reference

7 January 2021

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

7 January 2021

Atypical antipsychotics and glucose homeostasis.

1 reference

7 January 2021

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

7 January 2021

The impact of weight gain associated with atypical antipsychotic use in schizophrenia

1 reference

7 January 2021

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets

1 reference

7 January 2021

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis

1 reference

7 January 2021

The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy

1 reference

7 January 2021

Weight change with atypical antipsychotics in the treatment of schizophrenia

1 reference

7 January 2021

Atypical antipsychotics and glucose dysregulation: a systematic review

1 reference

7 January 2021

Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study

1 reference

7 January 2021

Early predictors of substantial weight gain in bipolar patients treated with olanzapine

1 reference

7 January 2021

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers

1 reference

7 January 2021

Disturbances of glucose and lipid metabolism during treatment with new generation antipsychotics

1 reference

7 January 2021

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

7 January 2021

An overview of the central control of weight regulation and the effect of antipsychotic medication

1 reference

7 January 2021

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17191265%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference